from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3472/-

LFCtreatmentdescriptionclass of inhibitor

-0.038

Amikacinug/mL Amikacintranslation

0.522

Cap5-10ug/mL Capreomycintranslation

0.425

Rox10-50 ug/mL Roxithromycintranslation

-0.306

SM2-5 ug/mL Streptomycintranslation

0.401

Tet5-10 ug/mL Tetracyclinetranslation

0.213

Rif0.2-5ug/mL Rifampicintranscription

1.204

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.482

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.478

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.037

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.219

Clofazimine10-13 ug/mL Clofaziminerespiration

0.449

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.098

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.040

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.917

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.038

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.176

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.426

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.514

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.015

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.850

KCN5-20 ug/mL Potassium cyaniderespiration

0.429

NaN30.2-2 mM Sodium aziderespiration

-0.303

Nigericin50 uM Nigericinrespiration

0.244

TRC10-150 ug/mL Triclosanrespiration

0.660

TRZ10-25 ug/mL Thioridazinerespiration

-1.094

Valinomycin0.5-10 uM Valinomycinrespiration

-0.796

ZnSO42 mM ZnSO4respiration

0.482

menadione6-10 ug/mL Menadionerespiration

0.025

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.752

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.341

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.318

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.121

NRP_1Non-replicating persistence stage 1dosRassociated

0.012

Amp0.2mg/mL AmpicillincellWall

0.147

Cephalexin20-100 ug/mL CephalexincellWall

-0.391

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.184

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.355

EMB10-20 ug/mL EthambutolcellWall

-0.728

Eta12-40 ug/mL EthionamidecellWall

-0.385

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.033

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.278

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.985

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.735

BZA0.12 mg/mL BenzamidearomaticAmides

-0.009

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.480

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.056

H2O24 mM hydrogen peroxideDNAdamaging

0.826

Levo10 ug/mL LevofloxacinDNAdamaging

-0.386

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.472

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.388

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.201

UVUV-irradiationDNAdamaging

1.604

ARP41-4 ug/mL Antitubercular compound ARP4?

0.402

Antimycin12.5-50 ug/mL Antimycin A?

-0.015

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.333

PA_110-50 ug/mL Antitubercular compound PA-1?

0.002

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.901

PA8240.2-2 ug/mL PA-824?

-0.807

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.083

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.533

Verapamil50 uM Verapamil?

-0.067

mercaptoethanol2 mM 2-Mercaptoethanol?

1.004

methoxatin10-20 ug/mL Methoxatin?